comparemela.com

Latest Breaking News On - Leverage trials of health innovation - Page 1 : comparemela.com

DiagnaMed Enhances CERVAI Brain Health Platform Commercialization Efforts In Canada

DiagnaMed Holdings (CSE: DMED) continues to progress with the commercialization of its CERVAI Brain Health AI Platform. The platform has recently been accepted into the Hamilton Ecosystem to Accelerate and Leverage Trials of Health Innovation.

DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.